Amalgamated Bank’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
Other funds holding ALGS
EC
VC
HA
VVM
BBA
NHAS
TCM
BC
Amalgamated Bank's ALGS Position: Q2 2022 in Review
Amalgamated Bank sold out of Aligos Therapeutics (ALGS) in Q2 2022, closing a stake of 138 shares — an estimated $7K sold.
Amalgamated Bank first reported a position in ALGS in Q1 2022 and held it in 1 quarter. The position peaked at $7K in Q1 2022. 59 funds tracked by Wall St. Rank hold ALGS as of Q2 2022.
- Amalgamated Bank reported no remaining Aligos Therapeutics position as of Q2 2022 after selling out during the quarter.
- Amalgamated Bank sold 138 Aligos Therapeutics shares in Q2 2022, an estimated $7K.
- Amalgamated Bank first reported a position in Aligos Therapeutics in Q1 2022 and held it in 1 quarter.
- Amalgamated Bank's Aligos Therapeutics position peaked at $7K in Q1 2022.
- 59 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q2 2022.
Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.